Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets

v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 50,400,377 $ 55,158,939
Restricted cash 101,090 100,866
Prepaid expenses 1,829,519 811,456
Other current assets 400,470 387,823
Total current assets 52,731,456 56,459,084
Intangibles, net 3,623,445 3,780,986
Total assets 56,354,901 60,240,070
Current liabilities:    
Accounts payable and accrued liabilities 1,489,485 1,131,104
Warrant liabilities - Placement Agent warrants 3,842,857
Total current liabilities 1,489,485 4,973,961
Non-current liabilities    
Warrant liabilities - Representative warrants 52,966 46,871
Total non-current liabilities 52,966 46,871
Total liabilities 1,542,451 5,020,832
Stockholders’ equity:    
Preferred stock, par value $0.0001 per share, 5,000,000 shares authorized; 0 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively
Common stock, par value $0.0001 per share, 500,000,000 shares authorized; 24,939,948 shares and 23,091,062 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively 2,494 2,309
Additional paid-in capital 127,643,001 125,208,624
Accumulated other comprehensive loss 46,898 18,766
Accumulated deficit (72,879,943) (70,010,461)
Total stockholders’ equity 54,812,450 55,219,238
Total liabilities and stockholders’ equity $ 56,354,901 $ 60,240,070